Behavioral characterization of mice lacking Trek channels

Frontiers in Behavioral Neuroscience

Volumn , Issue SEPTEMBER, 2012, Pages

  Mirkovic, Kelsey ^a   Palmersheim, Jaime ^a   Lesage, Florian ^b   Wickman, Kevin ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Anxiety; Behavior; Knockout; Memory; Morphine; Potassium channel

Indexed keywords

POTASSIUM CHANNEL; TREK PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; LEARNING TEST; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PLACE PREFERENCE; SEX DIFFERENCE; TRAAK GENE; TREK GENE; TREK1 GENE; TREK2 GENE;

EID: 84866665264     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00060     Document Type: Article

References (53)

1. Alloui, A., Zimmermann, K., Mamet, J., Duprat, F., Noel, J., Chemin, J., Guy, N., Blondeau, N., Voilley, N., Rubat-Coudert, C., Borsotto, M., Romey, G., Heurteaux, C., Reeh, P., Eschalier, A., and Lazdunski, M. (2006). TREK-1, a K+ channel involved in polymodal pain perception. EMBO J. 25, 2368-2376.
2. Anderson, G. R., Cao, Y., Davidson, S., Truong, H. V., Pravetoni, M., Thomas, M. J., Wickman, K., Giesler, G. J. Jr., and Martemyanov, K. A. (2010). R7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaine. Neuropsychopharmacology 35, 1040-1050.
3. Bang, H., Kim, Y., and Kim, D. (2000). TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family. J. Biol. Chem. 275, 17412-17419.
4. Bhatnagar, S., Sun, L. M., Raber, J., Maren, S., Julius, D., and Dallman, M. F. (2004). Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol. Behav. 81, 545-555.
5. Bockenhauer, D., Zilberberg, N., and Goldstein, S. A. (2001). KCNK2, reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat. Neurosci. 4, 486-491.
6. Bourin, M., and Hascoet, M. (2003). The mouse light/dark box test. Eur. J. Pharmacol. 463, 55-65.
7. Bozarth, M. A. (1987). Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res. 414, 77-84.
8. Bozarth, M. A., and Wise, R. A. (1986). Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. NIDA Res. Monogr. 67, 190-196.
9. Buckler, K. J., and Honore, E. (2005). The lipid-activated two-pore domain K+channel TREK-1 is resistant to hypoxia: implication for ischaemic neuroprotection. J. Physiol. 562, 213-222.
10. Caley, A. J., Gruss, M., and Franks, N. P. (2005). The effects of hypoxia on the modulation of human TREK-1 potassium channels. J. Physiol. 562, 205-212.
11. Canteras, N. S., Resstel, L. B., Bertoglio, L. J., Carobrez Ade, P., and Guimaraes, F. S. (2010). Neuroanatomy of anxiety. Curr. Top. Behav. Neurosci. 2, 77-96.
12. Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., and Tomkins, D. M. (1989). Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav. 32, 777-785.
13. Deng, P. Y., Xiao, Z., Yang, C., Rojanathammanee, L., Grisanti, L., Watt, J., Geiger, J. D., Liu, R., Porter, J. E., and Lei, S. (2009). GABAB receptor activation inhibits neuronal excitability and spatial learning in the entorhinal cortex by activating TREK-2 K+ channels. Neuron 63, 230-243.
14. Dere, E., Huston, J. P., and De Souza Silva, M. A. (2007). The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev. 31, 673-704.
15. Enyedi, P., and Czirjak, G. (2010). Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol. Rev. 90, 559-605.
16. Fink, M., Duprat, F., Lesage, F., Reyes, R., Romey, G., Heurteaux, C., and Lazdunski, M. (1996). Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J. 15, 6854-6862.
17. Fink, M., Lesage, F., Duprat, F., Heurteaux, C., Reyes, R., Fosset, M., and Lazdunski, M. (1998). A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 17, 3297-3308.
18. Gierten, J., Hassel, D., Schweizer, P. A., Becker, R., Katus, H. A., and Thomas, D. (2012). Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K+ channels. Biochim. Biophys. Acta 1818, 33-41.
19. Gu, W., Schlichthorl, G., Hirsch, J. R., Engels, H., Karschin, C., Karschin, A., Derst, C., Steinlein, O. K., and Daut, J. (2002). Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J. Physiol. 539, 657-668.
20. Guyon, A., Tardy, M. P., Rovere, C., Nahon, J. L., Barhanin, J., and Lesage, F. (2009). Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+channels. J. Neurosci. 29, 2528-2533.
21. Heurteaux, C., Guy, N., Laigle, C., Blondeau, N., Duprat, F., Mazzuca, M., Lang-Lazdunski, L., Widmann, C., Zanzouri, M., Romey, G., and Lazdunski, M. (2004). TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 23, 2684-2695.
22. Heurteaux, C., Lucas, G., Guy, N., El Yacoubi, M., Thummler, S., Peng, X. D., Noble, F., Blondeau, N., Widmann, C., Borsotto, M., Gobbi, G., Vaugeois, J. M., Debonnel, G., and Lazdunski, M. (2006). Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 9, 1134-1141.
23. Kalivas, P. W., and Duffy, P. (1987). Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241, 204-212.
24. Kang, D., Choe, C., and Kim, D. (2005). Thermosensitivity of the two-pore domain K+channels TREK-2 and TRAAK. J. Physiol. 564, 103-116.
25. Kim, Y., Gnatenco, C., Bang, H., and Kim, D. (2001). Localization of TREK-2 K+channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch. 442, 952-960.
26. Kucheryavykh, L. Y., Kucheryavykh, Y. V., Inyushin, M., Shuba, Y. M., Sanabria, P., Cubano, L. A., Skatchkov, S. N., and Eaton, M. J. (2009). Ischemia increases TREK-2 channel expression in astrocytes: relevance to glutamate clearance. Open Neurosci. J. 3, 40-47.
27. Latimer, L. G., Duffy, P., and Kalivas, P. W. (1987). Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241, 328-337.
28. Lau, A. A., Crawley, A. C., Hopwood, J. J., and Hemsley, K. M. (2008). Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice. Behav. Brain Res. 191, 130-136.
29. Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., Chen, L., Chen, T. M., Chin, M. C., Chong, J., Crook, B. E., Czaplinska, A., Dang, C. N., Datta, S., Dee, N. R., Desaki, A. L., Desta, T., Diep, E., Dolbeare, T. A., Donelan, M. J., Dong, H. W., Dougherty, J. G., Duncan, B. J., Ebbert, A. J., Eichele, G., Estin, L. K., Faber, C., Facer, B. A., Fields, R., Fischer, S. R., Fliss, T. P., Frensley, C., Gates, S. N., Glattfelder, K. J., Halverson, K. R., Hart, M. R., Hohmann, J. G., Howell, M. P., Jeung, D. P., Johnson, R. A., Karr, P. T., Kawal, R., Kidney, J. M., Knapik, R. H., Kuan, C. L., Lake, J. H., Laramee, A. R., Larsen, K. D., Lau, C., Lemon, T. A., Liang, A. J., Liu, Y., Luong, L. T., Michaels, J., Morgan, J. J., Morgan, R. J., Mortrud, M. T., Mosqueda, N. F., Ng, L. L., Ng, R., Orta, G. J., Overly, C. C., Pak, T. H., Parry, S. E., Pathak, S. D., Pearson, O. C., Puchalski, R. B., Riley, Z. L., Rockett, H. R., Rowland, S. A., Royall, J. J., Ruiz, M. J., Sarno, N. R., Schaffnit, K., Shapovalova, N. V., Sivisay, T., Slaughterbeck, C. R., Smith, S. C., Smith, K. A., Smith, B. I., Sodt, A. J., Stewart, N. N., Stumpf, K. R., Sunkin, S. M., Sutram, M., Tam, A., Teemer, C. D., Thaller, C., Thompson, C. L., Varnam, L. R., Visel, A., Whitlock, R. M., Wohnoutka, P. E., Wolkey, C. K., Wong, V. Y., Wood, M., Yaylaoglu, M. B., Young, R. C., Youngstrom, B. L., Yuan, X. F., Zhang, B., Zwingman, T. A., and Jones, A. R. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176.
30. Lesage, F., Terrenoire, C., Romey, G., and Lazdunski, M. (2000). Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J. Biol. Chem. 275, 28398-28405.
31. Liou, Y. J., Chen, T. J., Tsai, S. J., Yu, Y. W., Cheng, C. Y., and Hong, C. J. (2009). Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet. Genomics 19, 735-741.
32. Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 92, 180-185.
33. Maingret, F., Lauritzen, I., Patel, A. J., Heurteaux, C., Reyes, R., Lesage, F., Lazdunski, M., and Honore, E. (2000). TREK-1 is a heat-activated background K+ channel. EMBO J. 19, 2483-2491.
34. Maingret, F., Patel, A. J., Lesage, F., Lazdunski, M., and Honore, E. (1999). Mechano-or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J. Biol. Chem. 274, 26691-26696.
35. Maingret, F., Patel, A. J., Lesage, F., Lazdunski, M., and Honore, E. (2000). Lysophospholipids open the two-pore domain mechano-gated K+ channels TREK-1 and TRAAK. J. Biol. Chem. 275, 10128-10133.
36. Mazella, J., Petrault, O., Lucas, G., Deval, E., Beraud-Dufour, S., Gandin, C., El-Yacoubi, M., Widmann, C., Guyon, A., Chevet, E., Taouji, S., Conductier, G., Corinus, A., Coppola, T., Gobbi, G., Nahon, J. L., Heurteaux, C., and Borsotto, M. (2010). Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 8:e1000355. doi: 10.1371/journal.pbio.1000355
37. Medhurst, A. D., Rennie, G., Chapman, C. G., Meadows, H., Duckworth, M. D., Kelsell, R. E., Gloger, I. I., and Pangalos, M. N. (2001). Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res. Mol. Brain Res. 86, 101-114.
38. Menard, J., and Treit, D. (1999). Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23, 591-613.
39. Mirkovic, K., and Wickman, K. (2011). Identification and characterization of alternative splice variants of the mouse Trek2/Kcnk10 gene. Neuroscience 194, 11-18.
40. Moha ou Maati, H., Peyronnet, R., Devader, C., Veyssiere, J., Labbal, F., Gandin, C., Mazella, J., Heurteaux, C., and Borsotto, M. (2011). A human TREK-1/HEK cell line: a highly efficient screening tool for drug development in neurological diseases. PLoS ONE 6:e25602. doi: 10.1371/journal.pone.0025602
41. Moha Ou Maati, H., Veyssiere, J., Labbal, F., Coppola, T., Gandin, C., Widmann, C., Mazella, J., Heurteaux, C., and Borsotto, M. (2012). Spadin as a new antidepressant: absence of TREK-1-related side effects. Neuropharmacology 62, 278-288.
42. Murbartian, J., Lei, Q., Sando, J. J., and Bayliss, D. A. (2005). Sequential phosphorylation mediates receptor-and kinase-induced inhibition of TREK-1 background potassium channels. J. Biol. Chem. 280, 30175-30184.
43. Noel, J., Zimmermann, K., Busserolles, J., Deval, E., Alloui, A., Diochot, S., Guy, N., Borsotto, M., Reeh, P., Eschalier, A., and Lazdunski, M. (2009). The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception. EMBO J. 28, 1308-1318.
44. Patel, A. J., Honore, E., Maingret, F., Lesage, F., Fink, M., Duprat, F., and Lazdunski, M. (1998). A mammalian two pore domain mechano-gated S-like K+ channel. EMBO J. 17, 4283-4290.
45. Perlis, R. H., Moorjani, P., Fagerness, J., Purcell, S., Trivedi, M. H., Fava, M., Rush, A. J., and Smoller, J. W. (2008). Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology 33, 2810-2819.
46. Pravetoni, M., and Wickman, K. (2008). Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes Brain Behav. 7, 523-531.
47. Rudy, J. W., Huff, N. C., and Matus-Amat, P. (2004). Understanding contextual fear conditioning: insights from a two-process model. Neurosci. Biobehav. Rev. 28, 675-685.
48. Salas, R., Pieri, F., Fung, B., Dani, J. A., and De Biasi, M. (2003). Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor.J. Neurosci. 23, 6255-6263.
49. Sandoz, G., Levitz, J., Kramer, R. H., and Isacoff, E. Y. (2012). Optical control of endogenous proteins with a photoswitchable conditional subunit reveals a role for TREK1 in GABAB signaling. Neuron 74, 1005-1014.
50. Simon, P., Dupuis, R., and Costentin, J. (1994). Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 61, 59-64.
51. Talley, E. M., Solorzano, G., Lei, Q., Kim, D., and Bayliss, D. A. (2001). CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21, 7491-7505.
52. Wang, M., Song, J., Xiao, W., Yang, L., Yuan, J., Wang, W., Yu, Z., and Xie, M. (2012). Changes in lipid-sensitive two-pore domain potassium channel TREK-1 expression and its involvement in astrogliosis following cerebral ischemia in rats. J. Mol. Neurosci. 46, 384-392.
53. Xiao, Z., Deng, P. Y., Rojanathammanee, L., Yang, C., Grisanti, L., Permpoonputtana, K., Weinshenker, D., Doze, V. A., Porter, J. E., and Lei, S. (2009). Noradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels. J. Biol. Chem. 284, 10980-10991.